A. Mazo

Universidad Pontificia Bolivariana — Colombia

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index765citations29works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Research and Treatments(8), Cancer-related Molecular Pathways(6), Virus-based gene therapy research(5), Metabolism and Genetic Disorders(4), Pancreatic and Hepatic Oncology Research(3)

Publications29 total

Predictores de mortalidad en pacientes críticos con neumonía grave por coronavirus 2019 (COVID-19): un estudio observacional multicéntrico en Colombia
Acta Colombiana de Cuidado Intensivo·2024
Caracterización clínica y evolución de pacientes con sarcoidosis en dos instituciones en Medellín, Colombia, 2006-2020. Análisis basal y de seguimiento de una cohorte retrospectiva
Biosalud·2023Open Access
Uso de N-acetilcisteína en pacientes que desarrollaron hepatitis por medicamentos antituberculosos: revisión sistemática
Salud Uninorte·2023Open Access
A Novel Antibiotic Delivery Approach for Salvage of Cardiovascular-Implantable Electronic Devices with Localized Infection
EP Europace·2023Open Access
Concentrative nucleoside transporter 1 (hCNT1) promotes phenotypic changes relevant to tumor biology in a translocation-independent manner
Cell Death and Disease·2013· 35 citedOpen Access
Dual effects of β3 integrin subunit expression on human pancreatic cancer models
Cellular Oncology·2011· 6 citedOpen Access
p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors
Oncogene·2011· 487 cited
Targeted therapy to EGFR and HER2 combined with gemcitabine in a novel human pancreatic orthotopic model.
Journal of Clinical Oncology·2010
Dual Effects of<i>β</i><sub>3</sub>Integrin Subunit Expression on Human Pancreatic Cancer Models
Analytical Cellular Pathology·2010· 2 citedOpen Access
Optimized preclinical models for human pancreatic adenocarcinoma therapy research
Journal of Clinical Oncology·2007
The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity
Cell Death and Differentiation·2004· 20 citedOpen Access
Expression Profiles of a Human Pancreatic Cancer Cell Line upon Induction of Apoptosis Search for Modulators in Cancer Therapy
Oncology·2004· 15 cited
p16INK4a as a tumor suppressor with therapeutic applicability
Drugs of the Future·2003· 2 cited
Treatment based on a combination of the CYP2B1/cyclophosphamide system and p53 delivery enhances tumour regression in human pancreatic cancer.
Annals of Oncology·2001· 9 cited
Genetic background determines the response to adenovirus-mediated wild-type p53 expression in pancreatic tumor cells
Cancer Gene Therapy·1999· 27 cited
Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene
Gene Therapy·1999· 47 citedOpen Access
Synthesis of water-soluble bile pigments bound to amine-ended monomethoxypolyethyleneglycol: thiol addition and attempted enzymatic reduction of a bilindione derivative
Cellular and Molecular Life Sciences·1997Open Access
Retention of the fetoacinar pancreatic (FAP) protein to the endoplasmic reticulum of tumor cells.
PubMed·1993· 15 cited
Kinetic studies of the regulation of mitochondrial malate dehydrogenase by citrate
Biochemical Journal·1992· 44 citedOpen Access
Effect of the Buffer Concentration on the Separation of Lactate Dehydrogenase Isoenzymes from Different Sources by Electrophoresis
Analytical Letters·1991
page 1 of 2Next →

Frequent Co-authors

Josep Lluís Gelpí(7), Antonio Cortés(7), Sandra Pérez‐Torras(6), Joaquim Calbó(4), Neus Carbó(4), Elena Mercadé(3), Cristina Fillat(3), Anna Vidal-Pla(3), Manel Cascalló(3), Meritxell Carrió(2), A Dordal(2), Anna M. Gómèz‐Foix(2), S. Marchán(2), CarlosE. Domenech(2), J Bozal(2), Ana Luiza Raupp de Andrade(2), A. Villada(2), Santıago Imperial(2), M. Busquets(2), Rosa Miquel(2)